Welcome to our dedicated page for Wearable Devices Ltd. SEC filings (Ticker: WLDSW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Wearable Devices Ltd. SEC filings document the company’s foreign private issuer disclosures, business updates, and capital structure for its Nasdaq-listed ordinary shares and tradable warrants. Form 6-K reports include financial results, Mudra product and commercialization updates, equity financing activity, and material-event disclosures tied to its AI-powered touchless sensing wearables business.
The filing record also covers security-structure matters such as reverse share split disclosures, warrant adjustments, Nasdaq listing compliance, shareholder voting matters, and authorized share capital. Governance and compensation-related filings include updates to the company’s 2024 Global Equity Incentive Plan and incorporation of Form 6-K reports into Form S-8 and Form F-3 registration statements.
Wearable Devices Ltd. reported closing a previously announced private placement with a single institutional investor, raising aggregate gross proceeds of approximately $3.3 million before fees. The transaction followed dismissal, on August 10, 2026, of court proceedings that had temporarily halted the financing.
The company entered into a Cooperation Agreement with shareholder groups J.B.D Innovation Ltd. and Victor Tshuva & Co., resolving a governance dispute and related court actions. On the effective date, two directors will resign and four new independent directors will join, bringing the board to seven members. The shareholders agreed to withdraw their demand letter, terminate litigation, provide mutual releases and observe a two‑year standstill on efforts to change governance outside agreed channels.
In a related side letter, J.B.D committed that, if the board later determines the company lacks resources to fund at least 24 months of operations, it will provide at least $12.0 million in convertible debt financing over a 24‑month period, with detailed terms to be negotiated in good faith.
Wearable Devices Ltd. agreed on July 31, 2026 to a private placement with a single institutional investor for 240,000 ordinary shares at $3.285 per share and pre-funded warrants for up to 760,000 ordinary shares at $3.2849, together with ordinary warrants to purchase up to 1,000,000 ordinary shares at an exercise price of $3.16, for expected gross proceeds of approximately $3.3 million. The securities are unregistered and rely on Section 4(a)(2) and/or Regulation D, with a resale registration statement to be filed within 30 days and pursued to effectiveness.
The company plans to use net proceeds for commercialization of its Mudra products, development and manufacturing of next-generation product lines, advancement of its AI6 Labs initiatives, potential strategic transactions, and working capital and other general corporate purposes. A.G.P./Alliance Global Partners is exclusive placement agent, entitled to a 7% cash fee, a 1% management fee and expense reimbursement up to $50,000. The agreements impose near-term restrictions on new equity issuances, variable-rate transactions for six months, and 30‑day lock-ups for directors and executive officers.
An interim ex parte order from the Economic Department of the Haifa District Court temporarily prohibits advancing the offering and making any change to the company’s capital structure. A hearing is scheduled for August 12, 2026, and the transaction cannot be completed while the order remains in effect, with no assurance as to outcome or timing.
Wearable Devices Ltd. reports that shareholders J.B.D Innovation Ltd. and Victor Tshuva & Co. – Law Offices have initiated legal proceedings in the Economic Department of the Haifa District Court relating to its recently announced private placement of 1,000,000 ordinary shares and warrants to purchase up to 1,000,000 ordinary shares with a single institutional investor.
On August 2, 2026, the Court issued an interim ex parte order temporarily prohibiting the company from advancing the private placement or effecting any change in its capital structure, pending a hearing now set for August 12, 2026. The plaintiffs must post security including a third‑party guarantee and NIS 250,000 in additional security. Wearable Devices has filed a response seeking denial of the motion and intends to defend itself vigorously. The company states it cannot complete the private placement while the order remains in effect and gives no assurance regarding the timing or outcome of the proceedings.
J.B.D Innovation Ltd., Nissim Daniel, Victor Tshuva & Co. - Law Offices, and Victor Tshuva report beneficial ownership of 381,361 Ordinary Shares of Wearable Devices Ltd., representing 17.42% of the outstanding class of 2,189,469 Ordinary Shares as of June 17, 2026.
The reporting persons describe their objection to Wearable Devices’ agreement with a single institutional investor for a private placement of 1,000,000 Ordinary Shares (or equivalents) and warrants to purchase up to 1,000,000 Ordinary Shares at a combined price of $3.285 per share and accompanying warrant. They have initiated proceedings in the Economic Department of the District Court of Haifa seeking temporary injunctive relief, and on August 2, 2026 the court issued an ex parte temporary injunction that temporarily prohibits advancing the private placement or otherwise modifying the capital structure pending a hearing scheduled for August 16, 2026; the decision is described as preliminary and not a determination of the outcome. The reporting persons state that they intend to continue pursuing their rights and remedies.
An amended Schedule 13D for Wearable Devices Ltd. reports that reporting persons led by J.B.D Innovation Ltd. and Victor Tshuva & Co. – Law Offices sold an aggregate 162,000 Ordinary Shares on July 27, 2026 in open market transactions.
After these sales, the group reports beneficial ownership of 381,361 Ordinary Shares, representing 17.42% of Wearable Devices’ outstanding share capital, based on 2,189,469 shares outstanding as of June 17, 2026. J.B.D holds sole dispositive power over 315,361 shares (about 14.40%), while Victor Tshuva & Co. holds sole dispositive power over 66,000 shares (about 3.01%). The July 27, 2026 sale was executed at a weighted average price of approximately $3.812 per share, for aggregate gross proceeds of about $617,544 before costs.
Wearable Devices Ltd. reports that on July 27, 2026, shareholders J.B.D Innovation Ltd. and Victor Tshuva & Co. – Law Offices, holding approximately 24.8% of its voting rights, demanded that the board convene a special general meeting under Israeli law. Their proposals include amending provisions governing director elections and removals, removing four of the company’s five current directors, electing four nominees they designate, and asking the company to refrain from certain non‑ordinary‑course financing and strategic actions until the meeting.
The board is reviewing this demand with legal advisors and indicates there is no assurance regarding the outcome or timing. Wearable Devices also updates its risk disclosures to highlight that shareholder activism, including this campaign, proxy contests, related litigation, and any resulting changes in board composition or strategy could materially and adversely affect its business, financial condition, results of operations and the market price of its ordinary shares.
J.B.D Innovation Ltd., its owner and director Nissim Daniel, Victor Tshuva & Co. – Law Offices, and its owner Victor Tshuva together report beneficial ownership of 543,361 Ordinary Shares of Wearable Devices Ltd., representing 24.82% of the company’s outstanding 2,189,469 Ordinary Shares as of June 17, 2026.
J.B.D holds 477,361 shares (about 21.80%) and Victor Tshuva & Co. holds 66,000 shares (about 3.01%), for a total investment of approximately $951,425. On July 27, 2026, they sent a demand letter requesting a special general meeting to amend Articles provisions on director elections and removals, remove certain incumbent directors, elect four nominees they propose, and approve related compensation, exemption, indemnification, and insurance arrangements. J.B.D and Victor Tshuva & Co. agreed to act in concert regarding these shares and to transfer 66,000 shares to Victor Tshuva & Co. at $1.751 per share, while all parties expressly disclaim being part of a statutory group beyond their pecuniary interests.
Wearable Devices Ltd. is implementing a 1-for-3 reverse share split of its ordinary shares and publicly traded warrants to support continued listing on the Nasdaq Capital Market. Every three ordinary shares and three warrants will be consolidated into one share and one warrant, with warrant exercise prices adjusted proportionately.
After the reverse split, issued and outstanding ordinary shares will decrease from 6,568,408 to approximately 2,189,469, and publicly held warrants from 32,886 to approximately 10,962, while authorized share capital remains 500,000,000 ordinary shares. The shares and warrants will begin trading on a split-adjusted basis on June 22, 2026 under the existing symbols WLDS and WLDSW.
The company states that the primary goal is to increase its share price to regain compliance with Nasdaq’s $1.00 minimum bid price requirement and to help protect its continued listing status under updated Nasdaq rules.
Wearable Devices Ltd. reported the results of its Special General Meeting of Shareholders held on June 4, 2026. The meeting was initially convened at 11:00 a.m. Israel time but adjourned due to lack of quorum and reconvened at 12:30 p.m., when a quorum was present. Shareholders then approved, by the requisite majority, the single proposal described in the company’s previously distributed Notice and Proxy Statement. This report and its exhibits are also incorporated by reference into the company’s existing registration statements on Form S-8 and Form F-3.
Wearable Devices Ltd. filed a Form 6-K highlighting a press release that opens pre-orders for its new Mudra Pro device for qualified enterprise and OEM customers. Mudra Pro is a thinner, ergonomic wrist band that combines electromyography and inertial sensors with a new photoplethysmography sensor to capture muscle, motion, and cardiovascular signals.
The product is aimed at original equipment manufacturers, enterprise innovation teams, researchers, and developers, giving them access to specifications, a software development kit, and pilot-oriented resources. It is part of the company’s ai6 Labs initiative to advance AI-native neural sensing and intent-based user interfaces for AI and extended reality applications.